本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Unicycive Therapeutics, Inc.

0.6101
+0.00981.63%
盘后0.62900.0189+3.10%19:39 EDT
成交量:83.19万
成交额:51.18万
市值:7,303.20万
市盈率:-1.08
高:0.6318
开:0.6300
低:0.5920
收:0.6003
数据加载中...
2025/04/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/04/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/04/01

重要事件披露

Form 8-K - Current report
2025/03/31

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/19

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/14

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/19

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors